Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, June 25, 2008

Lemelson-MIT prize awarded to drug delivery inventor DeSimone

By Mass High Tech Staff


MIT has awarded its prestigious Lemelson-MIT $500,000 prize to Joseph DeSimone for his research developments in drug delivery, medical devices and green manufacturing.

DeSimone is a chemistry professor at North Carolina State University and the University of North Carolina at Chapel Hill, as well as co-founder of nanoparticles technology firm Liquidia Technologies.

His work includes development of plastic stents, now in clinical trials; plastics development technology using carbon dioxide instead of potentially toxic industrial acid; and nanoparticle development, through Liquidia, for drug delivery use, as well as flat-panel display applications.

Called the “Oscar for Inventors,” the Lemelson-MIT Prize recognizes the individuals behind inventions with global impact, according to MIT officials.

The inventor Jerome Lemelson and his wife, Dorothy, founded the Lemelson-MIT program in 1994. It is funded by the philanthropic Lemelson Foundation.


 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.